Beckman Coulter achieves CE Mark for its MDW-SARS CoV-2 application as an aid in identifying patients with risk of COVID-19 in A&E

23 Mar 2022

Read More
Studies have shown that MDW is significantly higher in patients with COVID-19 than those without
 
Contact Beckman Coulter (UK) Ltd
 

Related Articles

Beckman Coulter is introducing drug tests in agreement with Saladax Biomedical, Inc.

Beckman Coulter Introduces Antipsychotic Drug Testing to Address Unmet Clinical Need

Added: 18 Mar 2022

Beckman Coulter is introducing antipsychotic drug tests to laboratories and clinicians to address a…

Access AMH Advanced helps clinicians predict poor ovarian response

Innovative test from Beckman Coulter helps clinicians better personalise IVF treatments

Added: 15 Jun 2021

Beckman Coulter has launched a test that uses a validated cut-off to aid in the assessment of ovari…

Beckman Coulter’s DxA 5000 Fit

Workflow automation for medium-sized labs

Added: 8 May 2021

Beckman Coulter has launched the first workflow automation solution for medium-sized laboratories i…